VRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Valeant Pharmaceuticals International Inc's selling, general, & admin. expense for the three months ended in Mar. 2015 was $574 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2015 was $2,118 Mil.
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Valeant Pharmaceuticals International Inc Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2015 was 515.7 (Jun. 2014 ) + 504.1 (Sep. 2014 ) + 524.5 (Dec. 2014 ) + 573.8 (Mar. 2015 ) = $2,118 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Valeant Pharmaceuticals International Inc Annual Data
Valeant Pharmaceuticals International Inc Quarterly Data